|
1
|
Nass SJ and Davidson NE: The biology of
breast cancer. Hematol Oncol Clin North Am. 13:311–332. 1999.
View Article : Google Scholar
|
|
2
|
Bulun SE, Lin Z, Imir G, et al: Regulation
of aromatase expression in estrogen-responsive breast and uterine
disease: from bench to treatment. Pharmacol Rev. 57:359–383. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Simpson ER and Davis SR: Minireview:
aromatase and the regulation of estrogen biosynthesis - some new
perspectives. Endocrinology. 142:4589–4594. 2001.PubMed/NCBI
|
|
4
|
O’Neill JS, Elton RA and Miller WR:
Aromatase activity in adipose tissue from breast quadrants: a link
with tumour site. Br Med J (Clin Res Ed). 296:741–743.
1988.PubMed/NCBI
|
|
5
|
Bulun SE, Price TM, Aitken J, Mahendroo MS
and Simpson ER: A link between breast cancer and local estrogen
biosynthesis suggested by quantification of breast adipose tissue
aromatase cytochrome P450 transcripts using competitive polymerase
chain reaction after reverse transcription. J Clin Endocrinol
Metab. 77:1622–1628. 1993. View Article : Google Scholar
|
|
6
|
Harada N: Aberrant expression of aromatase
in breast cancer tissues. J Steroid Biochem Mol Biol. 61:175–184.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sasano H and Harada N: Intratumoral
aromatase in human breast, endometrial, and ovarian malignancies.
Endocr Rev. 19:593–607. 1998.PubMed/NCBI
|
|
8
|
Meng L, Zhou J, Sasano H, Suzuki T,
Zeitoun KM and Bulun SE: Tumor necrosis factor alpha and
interleukin 11 secreted by malignant breast epithelial cells
inhibit adipocyte differentiation by selectively down-regulating
CCAAT/enhancer binding protein alpha and peroxisome
proliferator-activated receptor gamma: mechanism of desmoplastic
reaction. Cancer Research. 61:2250–2255. 2001.
|
|
9
|
Zhou J, Gurates B, Yang S, Sebastian S and
Bulun SE: Malignant breast epithelial cells stimulate aromatase
expression via promoter II in human adipose fibroblasts: an
epithelial-stromal interaction in breast tumors mediated by
CCAAT/enhancer binding protein beta. Cancer Research. 61:2328–2334.
2001.
|
|
10
|
Avvisato CL, Yang X, Shah S, Hoxter B, Li
W, Gaynor R, Pestell R, Tozeren A and Byers SW: Mechanical force
modulates global gene expression and beta-catenin signaling in
colon cancer cells. J Cell Sci. 120:2672–2682. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shyy JY and Chien S: Role of integrins in
endothelial mechanosensing of shear stress. Circ Res. 91:769–775.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Alenghat FJ and Ingber DE:
Mechanotransduction: all signals point to cytoskeleton, matrix, and
integrins. Sci STKE. 2002:pe62002.PubMed/NCBI
|
|
13
|
Lopez JI, Mouw JK and Weaver VM:
Biomechanical regulation of cell orientation and fate. Oncogene.
27:6981–6993. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nelson CM and Bissell MJ: Of extracellular
matrix, scaffolds, and signaling: tissue architecture regulates
development, homeostasis, and cancer. Annu Rev Cell Dev Biol.
22:287–309. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Paszek MJ and Weaver VM: The tension
mounts: mechanics meets morphogenesis and malignancy. J Mammary
Gland Biol Neoplasia. 9:325–342. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ingber DE: Can cancer be reversed by
engineering the tumor microenvironment? Semin Cancer Biol.
18:356–364. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Le Beyec J, Xu R, Lee SY, Nelson CM, Rizki
A, Alcaraz J and Bissell MJ: Cell shape regulates global histone
acetylation in human mammary epithelial cells. Exp Cell Res.
313:3066–3075. 2007.PubMed/NCBI
|
|
18
|
Wiseman BS and Werb Z: Stromal effects on
mammary gland development and breast cancer. Science.
296:1046–1049. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Katz AJ, Tholpady A, Tholpady SS, Shang H
and Ogle RC: Cell surface and transcriptional characterization of
human adipose-derived adherent stromal (hADAS) cells. Stem Cells.
23:412–423. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yue W and Brodie AM: Mechanisms of the
actions of aromatase inhibitors 4-hydroxyandrostenedione,
fadrozole, and aminoglutethimide on aromatase in JEG-3 cell
culture. J Steroid Biochem Mol Biol. 63:317–328. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Morales L, Neven P and Paridaens R:
Choosing between an aromatase inhibitor and tamoxifen in the
adjuvant setting. Curr Opin Oncol. 17:559–565. 2005. View Article : Google Scholar : PubMed/NCBI
|
